IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION AND RVR 14 WEEKS TREATMENT IS NON-INFERIOR TO 24 WEEKS. POOLED ANALYSIS OF TWO SCANDINAVIAN TRIALS

Olav Dalgard, Hans Verbaan, Helmer Ring-Larsen, Kristian Bjoro

Research output: Contribution to journalPublished meeting abstractpeer-review

Original languageEnglish
Pages (from-to)1875
JournalHepatology
Volume48
Issue number4
Publication statusPublished - 2008
Event59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases - San Francisco, CA
Duration: 2008 Oct 312008 Nov 4

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Emergency medicine/Medicine/Surgery (013240200)

Subject classification (UKÄ)

  • Gastroenterology and Hepatology

Cite this